| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V50422 | (E/Z)-Zotiraciclib citrate-TG-02 citrate; SB-1317 citrate | 1204918-73-9 | (E/Z)-Zotiraciclib citrate (TG02 citrate; SB1317 citrate is a novel and potent CDK2, JAK2, and FLT3 inhibitorwith the potential for the treatment of cancer. |
|
V37604 | (R)-Apremilast ((R)-CC10004) | 608141-44-2 | R)-Apremilast ((R)-CC-10004) is the R-isomer of Apremilast (also known as CC-10004), which is a thalidomide analog and is a novel and orally bioavailable small molecule inhibitor of the phosphodiesterase 4 (PDE4) with potential anti-inflammatory activity. |
|
V44664 | (±)-Levomepromazine (Methotrimeprazine) | 851-68-3 | (±)-Levomepromazine is the racemate of Levomepromazine. |
|
V41444 | ARV-471 | 2229711-08-2 | ARV-471 (ARV471)is a first-in-class, selective and orally bioavailable PROTAC-based Estrogen Receptor (AR) degrader. |
|
V41400 | Bay-3827 | 2377576-35-5 | BAY-3827 is a potent and specific AMPK inhibitor (antagonist) with IC50s of 1.4 nM (10 µM ATP) and 15 nM (2 mM ATP). |
|
V37626 | Benzimidazole | 51-17-2 | Benzimidazole is a heterocyclic compound commonly and widely used for the synthesis of many bioactive molecules with various biological activities such as anti-cancer, anti-viral, anti-bacterial, anti-fungal, anti-helmintic, anti-inflammatory, proton pump inhibitor and anti-coagulant property. |
|
V41447 | BIIB068 | 1798787-27-5 | BIIB068 (BIIB-068) is a novelreversible and orally bioavailable BTK inhibitor with the potential to be used for autoimmune diseases such as systemic lupus erythematosus (SLE). |
|
V37648 | BMVC-8C3O | 1301708-12-2 | BMVC-8C3O is a novel ligand of DNA G-quadruplexe (G4) that can induce topological conversion of non-parallel to parallel forms in human telomeric DNA G4s. |
|
V41389 | C-021 (CCR4 antagonist) | 864289-85-0 | C021 (C-021; CCR4 antagonist) is a novel and potent CCR4 antagonist with anti-inflammatory activity. |
|
V44274 | Capmatinib HCl | 1029714-89-3 | Capmatinib (INC280; INCB28060) HCl is a potent, orally bioactive, selective, ATP-competitive c-Met kinase inhibitor (IC50=0.13 nM). |
|
V42163 | CCR6 antagonist 1 | 588674-64-0 | CCR6 antagonist 1 is a CCR6 antagonist with the potential tobe used in autoimmune diseases, e. |
|
V43698 | Cefpodoxime | 80210-62-4 | Cefpodoxime (R-3763; U-76253A) is a broad spectrumantibacterial agent that acts bybinding to penicillin binding proteins (PBPs), thus inhibiting peptidoglycan synthesis, leading to disruption ofbacterialcell wall biosynthesis. |
|
V41588 | Compound 6q | Compound 6q is a novel and potent steroidal anti-inflammatory agent that has the potential to be used in the treatment of IBD (inflammatory bowel diseases). | |
|
V49209 | DDO-7263 | 2254004-96-9 | DDO-7263 is a 1,2,4-Oxadiazole analogue and a potent Nrf2-ARE activator. |
|
V44747 | Fast Red Violet LB | 32348-81-5 | Fast Red Violet LB is a dye that can be used for staining TRAP (tartrate resistantacid phosphatase). |
|
V49031 | Fluridone | 59756-60-4 | Fluridone isan herbicide acting asan inhibitor of abscisic acid (ABA) biosynthesis. |
|
V41419 | gamma-Glu-Cys | 636-58-8 | Gamma-glutamylcysteine (amma-Glu-Cys) is a substrate for biosynthesis of L-glutathione by glutathione synthetase. |
|
V50576 | GRK6-IN-1 | 2677786-61-5 | GRK6-IN-1 (compound 18) is a potent inhibitor of G protein-coupled receptor kinase 6 (GRK6) with IC50 of 120 nM. |
|
V37640 | GS-441524 HCl | 2378280-82-9 | GS-441524 is an active metabolite of Remdesivir (GS-5734;Veklury) which is an FDA approved drug for treating the2019-nCoV (COVID-19 pandemic, CoronaVirus)infections. |
|
V41621 | Hyocholic Acid | 547-75-1 | Hyocholic Acid (3α,6α,7α-trihydroxy-5β-cholan-24-oic acid) is a biliary acid found mainlyin pig as well as in human urineat low concentrations, in particular,in urine samples from patients with cholestasis. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
